# OnCo record b-care-fragmentation (bottleneck). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/bottlenecks/b-care-fragmentation/>
  a schema:Thing ;
  onco:kind "bottleneck" ;
  schema:identifier "b-care-fragmentation" ;
  schema:name "Fragmented care and guideline gaps"@en ;
  schema:description "Patients fall between specialists, wait for referrals and often do not get the treatment guidelines say they should."@en ;
  schema:url <https://onco.cc/bottlenecks/b-care-fragmentation/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://doi.org/10.1136/bmj.m4087>, <https://www.england.nhs.uk/statistics/statistical-work-areas/cancer-waiting-times/>, <https://web.archive.org/web/20231029084627/https://practice.asco.org/quality-improvement/quality-programs/quality-oncology-practice-initiative> ;
  onco:related <https://onco.cc/collections/nccn/>, <https://onco.cc/collections/esmo-guidelines/>, <https://onco.cc/collections/nci-cancer-centers/>, <https://onco.cc/ideas/idea-acc-one-stop-breast-diagnostic-clinic/>, <https://onco.cc/ideas/idea-acc-28-day-diagnosis-standard/>, <https://onco.cc/ideas/idea-acc-national-virtual-mdt-rare-complex/>, <https://onco.cc/ideas/idea-acc-primary-care-shared-care-agreements/>, <https://onco.cc/ideas/idea-acc-tumour-board-implementation-audit/>, <https://onco.cc/ideas/idea-acc-diagnostic-interval-public-registry/>, <https://onco.cc/ideas/idea-acc-reflex-biomarker-panels-by-tumour/>, <https://onco.cc/ideas/idea-acc-rapid-diagnostic-centres-vague-symptoms/>, <https://onco.cc/ideas/idea-acc-embedded-decision-aids/>, <https://onco.cc/ideas/idea-acc-financial-toxicity-screening-at-diagnosis/>, <https://onco.cc/ideas/idea-acc-universal-asynchronous-second-opinion/>, <https://onco.cc/ideas/idea-acc-episode-payment-tied-to-concordance/>, <https://onco.cc/ideas/idea-acc-transition-handoff-medication-reconciliation/>, <https://onco.cc/ideas/idea-acc-pathway-capacity-simulation/>, <https://onco.cc/ideas/idea-cost-subcutaneous-community/>, <https://onco.cc/ideas/idea-cost-gold-card-oncology/>, <https://onco.cc/ideas/idea-cost-real-time-pa-fhir/>, <https://onco.cc/ideas/idea-cost-travel-teleoncology/> ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/head-and-neck/>, <https://onco.cc/cancers/esophageal/> ;
  onco:technologies <https://onco.cc/technologies/cgp/>, <https://onco.cc/technologies/liquid-biopsy/>, <https://onco.cc/technologies/companion-diagnostic/>, <https://onco.cc/technologies/ai-trial-matching/> ;
  onco:companies <https://onco.cc/companies/foundation-medicine/>, <https://onco.cc/companies/guardant-health/>, <https://onco.cc/companies/tempus/> ;
  onco:institutions <https://onco.cc/institutions/asco/>, <https://onco.cc/institutions/esmo/>, <https://onco.cc/institutions/nccn-org/>, <https://onco.cc/institutions/the-christie/>, <https://onco.cc/institutions/royal-marsden/> ;
  onco:terms <https://onco.cc/terms/standard-of-care/>, <https://onco.cc/terms/first-line/>, <https://onco.cc/terms/neoadjuvant-adjuvant/>, <https://onco.cc/terms/companion-diagnostic-term/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-hanna-bmj/> .